Berita Terbaru             -  INFORMASI AWAL UNTUK TENAGA PROFESIONAL KESEHATAN TERKAIT KEAMANAN PRODUK YANG MENGANDUNG BAHAN AKTIF RANITIDIN            -  INFORMASI AWAL UNTUK TENAGA PROFESIONAL KESEHATAN TERKAIT KEAMANAN PRODUK YANG MENGANDUNG BAHAN AKTIF RANITIDIN            -  Tecentriq (Atezolizumab) and New Important Identified Risk of Immune-Related Myositis            -  Actemra® (Tocilizumab) and Risk of Hepatotoxicity            -  Buletin Berita MESO Volume 37, No 1 Edisi Juni 2019

Event

Dear Colleagues,

 

We would like to inform you that Uppsala Monitoring Centre (UMC) and JSS University are pleased to announce their third Asia Pacific Pharmacovigilance Training Course, which will take place in Mysore, India from 16th to 27th January 2017.

 Read More

Dear Colleagues,

 

We would like to inform you the 16th Annual Meeting of the International Society of Pharmacovigilance (in association with Society of Pharmacovigilance India) will be held in Agra, India, from the 16th - 19th of October 2016.

 Read More

Kepada Yth.

Pimpinan dan Penanggungjawab Farmakovigilans Industri Farmasi

di tempat

 Read More

Sorry, english version not available yet

 Read More

Sorry, english version not available yet

 Read More

How do you think the content and appearance of this website?




logo dsras Email Rapid Alert System

Selamat email anda telah berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia.

 

logo dsras Email Rapid Alert System

Anda ingin berhenti berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia?